Related Experiment Videos
Practical guidelines for initiation of beta-adrenergic blockade in patients with chronic heart failure
The American Journal of Cardiology
|March 15, 1997
Abstract:
Recent developments in the treatment of chronic heart failure have lead to the use of beta blockers to improve ventricular function and symptoms, and to reverse or slow pathologic remodeling of the failing heart. Little practical information exists in the literature on how to initiate this therapy and how to select the proper beta-blocking agent. This editorial examines which beta-blocking agents are best tolerated and why, and describes how best to initiate treatment with these agents.
Insights
Beta blockers can improve heart function in chronic heart failure patients. This editorial guides clinicians on selecting and initiating beta-blocker therapy for optimal patient outcomes.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Chronic heart failure (CHF) management has advanced with beta-blocker therapy.
- Beta blockers improve ventricular function, alleviate symptoms, and slow cardiac remodeling in CHF.
- Practical guidance on initiating beta-blocker therapy and agent selection is lacking.